AIMEE MULHEARN: Open Payments
NPI 1114366325 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,586 in 124 payments from 12 companies in 2025. Trend: 2023 $2,825 · 2024 $2,724 · 2025 $2,586
Food & beverage: $2,534Education: $51
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 37 | $647 |
| AstraZeneca Pharmaceuticals LP | 22 | $557 |
| GENZYME CORPORATION | 16 | $393 |
| Viatris Specialty LLC | 15 | $232 |
| Regeneron Healthcare Solutions, Inc. | 9 | $213 |
| CSL Behring | 7 | $174 |
| Amgen Inc. | 6 | $139 |
| Verona Pharma, Inc. | 5 | $89 |
| Boston Scientific Corporation | 1 | $41 |
| Insmed, Inc. | 2 | $40 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, TRELEGY ELLIPTA, YUPELRI, FASENRA, Hizentra, BREZTRI.
Industry payments across LA — which companies pay providers there.
